Filter
440
Filtered Results: 440
Text search:
National
Institute
for
Viral
Disease
Control
and
Prevention,
China
Featured
Recommendations
61
New Publications
64
Language
Document type
No document type
157
Guidelines
129
Studies & Reports
82
Manuals
31
Strategic & Response Plan
18
Fact sheets
11
Situation Updates
5
Training Material
4
Resource Platforms
2
Infographics
1
Countries / Regions
Global
19
India
15
South Africa
13
Brazil
10
Western and Central Europe
10
Latin America and the Carribbean
8
Africa
8
Germany
7
Russia
7
Vietnam
6
Kenya
5
Mozambique
5
Peru
4
Colombia
4
Ecuador
4
Bolivia
4
Angola
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Asia
4
Spain
4
Guinea-Bissau
3
Uganda
3
Syria
3
China
3
Ukraine
3
Myanmar / Burma
3
East and Southern Africa
3
Eastern Europe
3
Portugal
3
Guinea
2
Ethiopia
2
Pakistan
2
Bangladesh
2
Papua New Guinea
2
Namibia
2
Venezuela
2
Laos
2
France
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Ghana
1
Zimbabwe
1
South Sudan
1
Jordan
1
Turkey
1
Tanzania
1
Cambodia
1
Thailand
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
North Macedonia
1
Honduras
1
Botswana
1
El Salvador
1
Mexico
1
Chile
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Albania
1
North America
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
116
Clinical Guidelines
62
Public Health
18
Women & Child Health
9
Key Resources
8
Pharmacy & Technologies
7
Capacity Building
2
Toolboxes
COVID-19
142
HIV
77
Rapid Response
28
TB
19
AMR
17
Mental Health
15
Planetary Health
15
Ebola
10
Global Health Education
9
NCDs
8
Refugee
7
NTDs
7
Specific Hazards
5
Disability
4
Pharmacy
4
Polio
3
Conflict
2
Natural Hazards
2
Zika
2
Health Financing Toolbox
2
Cholera
1
Health Financing
1
Guidance for General Medical and Specialised Mental Health Care Settings
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curt...
The National Strategy for Natural Disaster, Prevention, Response and Mitigation to 2020, which o...
his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exp...
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care ... COVID-19 cases. It is intended for policy makers, public health and infection prevention and control professionals, health care managers and health workers.
The Annex provides advice on how to manufacture non-medical masks. It is intended for those making non-medical masks at home and for mask manufacturers
INTRODUCTION: The COVID-19 pandemic has disrupted health systems around the world. The objectives of this study are to estimate the overall effect of the pandemic on essential health service use and outcomes in Mexico, describe observed ... predicted trends in services over 24 months, and to estimate the number of visits lost through December 2020.
METHODS: We used health information system data for January 2019 to December 2020 from the Mexican Institute of Social Security (IMSS), which provides health services for more than half of Mexico's population-65 million people. Our analysis includes nine indicators of service use and three outcome indicators for reproductive, maternal and child health and non-communicable disease services. We used an interrupted time series design and linear generalised estimating equation models to estimate the change in service use and outcomes from April to December 2020. Estimates were expressed using average marginal effects on the risk ratio scale.
RESULTS: The study found that across nine health services, an estimated 8.74 million patient visits were lost in Mexico. This included a decline of over two thirds for breast and cervical cancer screenings (79% and 68%, respectively), over half for sick child visits and female contraceptive services, approximately one-third for childhood vaccinations, diabetes, hypertension and antenatal care consultations, and a decline of 10% for deliveries performed at IMSS. In terms of patient outcomes, the proportion of patients with diabetes and hypertension with controlled conditions declined by 22% and 17%, respectively. Caesarean section rate did not change.
CONCLUSION: Significant disruptions in health services show that the pandemic has strained the resilience of the Mexican health system and calls for urgent efforts to resume essential services and plan for catching up on missed preventive care even as the COVID-19 crisis continues in Mexico.
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
Access to medical personal protective equipment (PPE) is essential for routine healthcare delivery, and a critical tool for containing outbreaks, a...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identi...
Este documento brinda orientaciones y directrices técnicas para mantener las acciones para la prevención y control de la tuberculosis (TB), ante la coyuntura que representa la pandemia del COVID-1...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World
Institute of Medicine (US) Committee on Nervous System Disorders in Developing Countries.
Wash...
Epilepsy: a public health imperative
recommended
This is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public health response required at global, regional and ... levels.
The reports highlights major gaps in awareness, diagnosis, treatment, and health policies through a series of appalling numbers. With around 50 million people affected worldwide, epilepsy is one of the most common and serious brain disorders. Nearly 80% of people with epilepsy live in low-income and middle-income countries
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb...
